- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06004089
Vaginal Transluminal Endoscopic Sacrocolpopexy
August 18, 2023 updated by: Elif Cansu Gundogdu, Dr. Lutfi Kirdar Kartal Training and Research Hospital
Vaginal Transluminal Endoscopic Sacrocolpopexy: A Minimal Invasive Approach for Pelvic Organ Prolapse
This study aims to evaluate the outcomes of V-NOTES sacrocolpopexy following vaginal hysterectomy, focusing on perioperative and early postoperative results.
The impact of V-NOTES sacrocolpopexy on patients' quality of life is investigated using validated assessment tools.
Additionally, operative time, complications, pain scores were assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients who presented to the obstetrics and gynecology outpatient clinic with complaints related to pelvic organ prolapse, had stage III or IV prolapse according to POP-Q classification, were between 45 and 79 years old, had no contraindications for pneumoperitoneum and Trendelenburg position, and were eligible to perform transvaginal NOTES and gave written informed consent were included in the study.
Demographic data, age, medical and surgical history, body mass index (BMI), operation time, preoperative and postoperative haemoglobin levels, perioperative complications and length of hospital stay were collected.
Pelvic organ prolapse quantification (POP-Q) scores were evaluated before and 1 month after surgery.
Quality of life was evaluated before and 1 month after surgery with the Turkish-validated Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20).
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kartal
-
Istanbul, Kartal, Turkey
- Kartal Dr. Lütfi Kirdar City Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients who presented to the obstetrics and gynecology outpatient clinic with complaints related to pelvic organ prolapse, had stage III or IV prolapse according to POP-Q classification, were between 45 and 79 years old, had no contraindications for pneumoperitoneum and Trendelenburg position, and were eligible to perform transvaginal NOTES were included in the study.
Exclusion Criteria:
- Patients with previous pelvic inflammatory disease, deep endometriosis, severe pelvic adhesions, and patients who are at risk of gynecological malignancy and are not suitable for transvaginal surgery were not included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: V NOTES Sacrocolpopexy arm
V-NOTES sacrocolpopexy was performed who met the eligibility criteria and gave written informed consent.
Pelvic organ prolapse quantification (POP-Q) scores were evaluated before and 1 month after surgery.
Quality of life was evaluated before and 1 month after surgery with the Turkish-validated Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20).
|
The procedure involved a single-port laparoscopic surgery through the vaginal route, aiming to restore pelvic floor function by suspending the vagina to the anterior longitudinal ligament.
The surgical approach differs from conventional methods, as these procedures are conducted through abdominal or vaginal routes without the aid of laparoscopic cameras, However, in our approach, we uniquely combine the widely acknowledged gold standard sacrocolpopexy procedure using vaginal route with laparoscopic camera assistance.
No experimental drugs or devices were employed; only the surgical approach was modified.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The impact of V-NOTES sacrocolpopexy on patients' quality of life regarding daily activities and emotional health
Time Frame: 1 month
|
The impact of pelvic floor function on daily activities and emotional health of life was evaluated before and 1 month after surgery with the Turkish-validated Pelvic Floor Impact Questionnaire (PFIQ-7).
This study aimed to evaluate the outcomes of V-NOTES sacrocolpopexy following vaginal hysterectomy, focusing on perioperative and early postoperative results.
|
1 month
|
|
The impact of V-NOTES sacrocolpopexy on patients' quality of life regarding level of discomfort
Time Frame: 1 month
|
The level of discomfort associated with symptoms was evaluated before and 1 month after surgery with the Turkish-validated Pelvic Floor Impact Questionnaire (PFIQ-7).
This study aimed to evaluate the outcomes of V-NOTES sacrocolpopexy following vaginal hysterectomy, focusing on perioperative and early postoperative results.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Elif Gundogdu, M.D.Dr, Kartal Dr. Lütfi Kirdar City Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
April 1, 2022
Study Completion (Actual)
May 1, 2022
Study Registration Dates
First Submitted
August 11, 2023
First Submitted That Met QC Criteria
August 18, 2023
First Posted (Actual)
August 22, 2023
Study Record Updates
Last Update Posted (Actual)
August 22, 2023
Last Update Submitted That Met QC Criteria
August 18, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/514/222/30
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Hillel Yaffe Medical CenterCompletedHysterectomy | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Israel
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Wolfson Medical CenterRecruiting
-
Queen's UniversityNot yet recruitingPelvic Organ Prolapse (POP)Canada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
A.M.I. Agency for Medical Innovations GmbHActive, not recruitingProlapse | Pelvic Organ Prolapse (POP) | SacrocolpopexyGermany
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
Clinical Trials on V NOTES Sacrocolpopexy
-
Havva Betül BacakRecruitingPelvic Organ ProlapseTurkey
-
Azienda Ospedaliero, Universitaria PisanaNot yet recruiting
-
Fundacion para la Formacion e Investigacion Sanitarias...Completed
-
Gaziosmanpasa Research and Education HospitalCompleted
-
The University of Texas Health Science Center,...CompletedSterility, FemaleUnited States
-
Sanliurfa Education and Research HospitalCompleted
-
The Oregon ClinicNorthwestern UniversityCompletedCholecystitisUnited States
-
University Of PerugiaUnknownPelvic Organ ProlapseItaly
-
Rambam Health Care CampusCompletedPelvic Organ ProlapseIsrael
-
Femke van ZantenUnknownPelvic Organ ProlapseIreland